1922
J. GROVER, S. K. ROY, AND S. M. JACHAK
4. Ouyang, G.; Cai, X.-J.; Chen, Z.; Song, B.-A.; Bhadury, P. S.; Yang, S.; Jin, L.-H.; Xue,
W.; Hu, D.-Y.; Zeng, S. Synthesis and antiviral activities of pyrazole derivatives contain-
ing an oxime moiety. J. Agric. Food Chem. 2008, 56, 10160–10167.
5. Stein, R. G.; Biel, J. H.; Singh, T. Antimalarials: 4-Substituted 1H-pyrazolo [3,4-b]
quinolines. J. Med. Chem. 1970, 13, 153–155.
6. Mishra, S.; Karmodiya, K.; Surolia, N.; Surolia, A. Synthesis and exploration of
novel curcumin analogues as anti-malarial agents. Bioorg. Med. Chem. Lett. 2008, 16,
2894–2902.
7. Sweeney, Z. K.; Harris, S. F.; Arora, N.; Javanbakht, H.; Li, Y.; Fretland, J.; Davidson, J. P.;
Billedeau, J. R.; Gleason, S. K.; Hirschfeld, D. Design of annulated pyrazoles as inhibitors of
HIV-1 reverse transcriptase II. J. Med. Chem. 2008, 51, 7449–7458.
8. Lynch, C. L.; Hale, J. J.; Budhu, R. J.; Gentry, A. L.; Finke, P. E.; Caldwell, C. G.; Mills,
S. G.; MacCoss, M.; Shen, D.-M.; Chapman, K. T. CCR5 antagonists: 3-(Pyrrolidin-1-yl)
propionic acid analogues with potent anti-HIV activity. Org. Lett. 2003, 5, 2473–2475.
9. Tanitame, A.; Oyamada, Y.; Ofuji, K.; Fujimoto, M.; Iwai, N.; Hiyama, Y.; Suzuki, K.;
Ito, H.; Terauchi, H.; Kawasaki, M. Synthesis and antibacterial activity of a novel series of
potent DNA gyrase inhibitors: Pyrazole derivatives. J. Med. Chem. 2004, 47, 3693–3696.
10. Holla, B. S.; Mahalinga, M.; Karthikeyan, M. S.; Akberali, P. M.; Shetty, N. S. Synthesis
of some novel pyrazolo[3,4-d]pyrimidine derivatives as potential antimicrobial agents.
Bioorg. Med. Chem. Lett. 2006, 14, 2040–2047.
11. Baraldi, P. G.; Balboni, G.; Pavani, M. G.; Spalluto, G.; Tabrizi, M. A.; Clercq, E. D.;
Balzarini, J.; Bando, T.; Sugiyama, H.; Romagnoli, R. Design, synthesis, DNA binding,
and biological evaluation of water-soluble hybrid molecules containing two pyrazole
analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor
agent CC-1065 and polypyrrole minor groove binders. J. Med. Chem. 2001, 44, 2536–
2543.
12. Lin, R.; Chiu, G.; Yu, Y.; Connolly, P. J.; Li, S.; Lu, Y.; Adams, M.; Fuentes-Pesquera,
A. R.; Emanuel, S. L.; Greenberger, L. M. Design, synthesis, and evaluation of 3,4-
disubstituted pyrazole analogues as anti-tumor CDK inhibitors. Bioorg. Med. Chem. Lett.
2007, 17, 4557–4561.
13. Colotta, V.; Cecchi, L.; Filacchioni, G.; Melani, F.; Palazzino, G.; Martini, C.;
Giannaccini, G.; Lucacchini, A. Synthesis, binding studies, and structure–activity rela-
tionships of 1-aryl-and 2-aryl [1] benzopyranopyrazol-4-ones, central benzodiazepine
receptor ligands. J. Med. Chem. 1988, 31, 1–3.
14. Kidwai, M.; Singhal, K.; Rastogi, S. A convenient K2CO3-catalysed regioselective
synthesis for benzopyrano[4,3-c]pyrazoles in aqueous medium. Heterocycles 2007, 71,
569–576.
15. Colotta, V.; Cecchi, L.; Melani, F.; Palazzino, G.; Filacchioni, G. The correct synthesis of
2,3-dihydro-2-aryl-4-r-[1] benzopyrano [4, 3-c] pyrazole-3-ones. Tetrahedron Lett. 1987,
28, 5165–5168.
16. Chantegrel, B.; Nodi, A.-I.; Gelin, S. 4-Oxo-1H-and-2H-[1]benzopyrano[4,3-c]pyrazoles:
Preparation from 4-hydroxycoumarin or 3-chromonecarboxylic acid derivatives. Tetra-
hedron Lett. 1983, 24, 381–384.
17. Stadlbauer, W.; Hojas, G. Ring closure reactions of 3-arylhydrazonoalkyl-quinolin-2-ones
to 1-aryl-pyrazolo [4, 3-c] quinolin-2-ones. J. Heterocycl. Chem. 2004, 41, 681–690.
18. Manvar, A.; Bochiya, P.; Virsodia, V.; Khunt, R.; Shah, A. Microwave-assisted and
Zn[l-proline]2-catalyzed tandem cyclization under solvent-free conditions: Rapid synthesis
of chromeno[4,3-c]pyrazol-4-ones. J. Mol. Catal. A: Chem. 2007, 275, 148–152.
˜
19. Padilla-Martinez, I. I.; Flores-Larios, I. Y.; GarcAa-Baez, E. V.; Gonzalez, J.; Cruz, A.;
˜
MartAnez-Martinez, F. J. X-ray supramolecular structure, NMR spectroscopy, and
synthesis of 3-methyl-1-phenyl-1-H-chromeno[4,3-c]pyrazol-4-ones formed by the